Apoptosis induced by PGC-1β in breast cancer cells is mediated by the mTOR pathway

Libin Wang1, Qilun Liu, Fang Li

  • 1Life Science College, Shaanxi Normal University, Xi'an 710062, P.R. China.

Oncology Reports
|July 24, 2013
PubMed

Insights

Peroxisome proliferator-activated receptor-γ coactivator-1β (PGC-1β) regulates mitochondrial activity. PGC-1β knockdown impacts the mTOR pathway, affecting cell apoptosis in breast cancer cells.

Area of Science:

  • Cell Biology
  • Molecular Biology
  • Biochemistry

Background:

  • Peroxisome proliferator-activated receptor-γ coactivator-1β (PGC-1β) is a key regulator of mitochondrial biogenesis.
  • The precise molecular mechanisms governing PGC-1β's function are not fully understood.
  • Understanding PGC-1β's role is crucial for investigating cellular energy metabolism and disease pathways.

Purpose of the Study:

  • To elucidate the mechanism by which PGC-1β influences cellular signaling pathways.
  • To investigate the relationship between PGC-1β, the mammalian target of rapamycin (mTOR) pathway, and mitochondrial activity.
  • To determine the role of PGC-1β in regulating apoptosis in breast cancer cells.

Main Methods:

  • Short-hairpin RNA (shRNA) was used to knockdown endogenous PGC-1β in MDA-MB-231 breast cancer cells.
  • Expression levels of mTOR pathway-related genes were analyzed.
  • Western blotting was employed to assess the phosphorylation status of key proteins including AMPK, Rictor, Raptor, S6, and Akt.
  • Cell apoptosis was evaluated.

Main Results:

  • Knockdown of PGC-1β significantly decreased the expression of mTOR pathway-related genes.
  • Inhibition of AMPK phosphorylation, Rictor (Thr1135), Raptor, and S6 protein phosphorylation was observed post-PGC-1β knockdown.
  • Akt phosphorylation (Ser473) was upregulated, coinciding with increased cell apoptosis.
  • PGC-1β and mTOR levels showed a positive correlation with overall mitochondrial activity.

Conclusions:

  • PGC-1β plays a critical role in regulating the mTOR signaling pathway in breast cancer cells.
  • The balance between PGC-1β and mTOR signaling is implicated in the orchestration of cell apoptosis.
  • These findings highlight PGC-1β as a potential mediator in breast cancer progression through the mTOR pathway.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Apoptosis01:30

Apoptosis

Apoptosis is a combination of two Greek words, 'apo' and 'ptosis,' meaning separation and falling off, respectively. Hippocrates used this word to describe gangrene, which was caused due to bandaging of fractured bones. Apoptosis was distinguished from necrosis in 1970 when John Kerr reported observations of morphological changes occurring during apoptosis. During one experiment, he observed that the disruption of blood supply to the liver tissue resulted in a size reduction of the tissue.